5 Most Promising Companies offering hope to patients with Niemann-Pick Type C

Niemann–Pick is a rare autosomal recessive inherited disease that is characterized by excessive accumulation of cholesterol and lipids in cells, leading to apoptosis and neural degeneration. The disease affects numerous body parts such as the brain, nerves, liver, spleen, bone marrow and lungs. Those suffering from the disease suffer from lack of coordination, dystonia; sleep disturbances, difficult in eating and swallowing and frequent bouts of pneumonia.

5 Most Promising Companies offering hope to patients with Niemann-Pick Type C

2-year-old girl battles rare 'childhood Alzheimer's' disorder

Jill Beirl – NNPDF

Recent advances in the treatment of Niemann pick disease type C: A mini-review - ScienceDirect

5 Most Promising Companies offering hope to patients with Niemann-Pick Type C

Parents of twins with Niemann-Pick find a treatment

5 Most Promising Companies offering hope to patients with Niemann-Pick Type C

Therapeutic intervention for Niemann–Pick type C disease must target

Parents of kids with Niemann Pick C advocate for adrabetadex

Niemann-Pick Disease Type C Market to Proliferate by 2032, Predicts DelveInsight Key Companies in the Market - Azafaros A.G., Cyclo Therapeutics, Inc., ZevraDenmark, Genzyme, IntraBio Inc, Mandos Health

Niemann Pick C Awareness Group